SYNCOMF — Syncom Formulations (India) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapHigh Flyer

Annual balance sheet for Syncom Formulations (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	124	784	477	745	1,357
Net Total Accounts Receivable
Net Total Receivables	440	748	676	833	1,076
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	865	1,898	1,398	1,817	2,748
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	459	446	527	688	723
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,805	2,916	3,082	3,778	4,047
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	278	967	783	1,132	1,065
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	349	1,041	860	1,218	1,165
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1,457	1,876	2,222	2,560	2,881
Total Liabilities & Shareholders' Equity	1,805	2,916	3,082	3,778	4,047
Total Common Shares Outstanding